Announcements Trials

Browse Landscape

Sponsor

Conditions

Ovarian Neoplasms 17 Fallopian Tube Neoplasms 17 Glioblastoma 7 Colorectal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 6 Carcinoma, Renal Cell 6 Brenner Tumor 6 Melanoma 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Gliosarcoma 4 Breast Neoplasms 4 Brain Neoplasms 4 Triple Negative Breast Neoplasms 3 Recurrent Squamous Cell Lung Carcinoma 3 Oligodendroglioma 3 Neoplasm Metastasis 3 Lymphoma, Large B-Cell, Diffuse 3 Colonic Neoplasms 3 Uveal Melanoma 2 Spinal Cord Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Medulloblastoma 2 Glioma 2 Endometrial Adenocarcinoma 2 Carcinoma 2 Astrocytoma 2 Adenocarcinoma of Lung 2

Interventions

Erlotinib Hydrochloride 1 Botulinum Toxins, Type A 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hereditary leiomyomatosis and renal cell cancer × Disulfides × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡